JERUSALEM (JTA) — South Korean media have repeated anti-Semitic canards about Jews and money in the face of a corporate merger vote.
“Jews are known to wield enormous power on Wall Street and in global financial circles,” according to a column on a South Korean news website. “It is a well-known fact that the U.S. government is swayed by Jewish capital.”
The news was first reported Thursday by the Times of Israel.
The South Korean website MoneyToday also wrote about Jewish influence in “a number of domains,” citing a financial industry source.
On July 17, the shareholders of the construction company Samsung C&T will vote on a merger with Cheil Industries. Both are subsidiaries of the Samsung Group, the country’s largest family-controlled conglomerate, and the merger is part of a consolidation effort.
Lobbying against the merger, which is popular in South Korea, is the New York-based hedge fund Elliott Associates, which is owned and managed by Paul Singer, who is Jewish.
Singer is described on the news website Mediapen.com as a “greedy, ruthless head of a notorious hedge fund” that has received support from the Institutional Shareholder Services, or ISS, a proxy advisory firm, because of “Jewish money.”
Articles claimed that ISS is under Jewish influence because it is owned by MSCI, formerly Morgan Stanley Capital International, “which is owned by Jewish major shareholders.” MSCI sold ISS more than a year ago, according to the Times of Israel.
“According to the finance industry, the fact that Elliott and ISS are both Jewish institutions cannot be ignored,” MoneyToday reported. “Elliott is led by a Jew, Paul E. Singer, and ISS is an affiliate of Morgan Stanley Capital International (MSCI), whose key shareholders are Jewish. According to a source in the finance industry, Jews have a robust network demonstrating influence in a number of domains.”
Help ensure Jewish news remains accessible to all. Your donation to the Jewish Telegraphic Agency powers the trusted journalism that has connected Jewish communities worldwide for more than 100 years. With your help, JTA can continue to deliver vital news and insights. Donate today.
